| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Graduate Program in Immunology,
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390; and
Department of Pathology, University of Chicago, Chicago, IL 60637
NK cells are the primary effectors mediating acute rejection of incompatible bone marrow cell grafts. To reduce rejection, we evaluated the ability of chloroquine (CHQ) to prevent perforin-dependent NK cell activity. Perforin is a key cytotoxic component released from the lytic granules of activated NK cells. Generation of functional perforin requires an acidic protease activity that occurs in the secretory, lytic lysosomes. Our hypothesis was that CHQ, a lysosomotropic reagent, would raise the pH of the acidic compartment in which perforin is processed and thereby block perforin maturation and cytotoxicity. We have measured NK cytotoxicity in vivo by clearance of YAC-1 tumor cells from the lungs and by rejection of incompatible bone marrow transplants and in vitro by cytolysis of YAC-1 and Jurkat cells. The engraftment of bone marrow cells was monitored by recolonization of the spleen with hemopoietic cells from transplants of MHC class I-deficient bone marrow cells into lethally irradiated recipient mice. Transplant rejection was compared in two inbred strains of mice: 129, which apparently use perforin-dependent cytotoxicity, and C57BL/6, in which rejection can be perforin-independent. CHQ treatment reduced NK cell activity in 129 mice in which perforin is important for mediating rejection. CHQ affected the fraction of NK cell cytolysis that was Fas independent. In addition, we found that CHQ prevents perforin processing by LAK cells in vitro. These data indicate that CHQ may impair rejection of incompatible bone marrow transplants and other functions mediated by NK and cytotoxic T cells.
This article has been cited by other articles:
|
|
 |
|
  V. Mateo, M. Menager, G. de Saint-Basile, M.-C. Stolzenberg, B. Roquelaure, N. Andre, B. Florkin, F. le Deist, C. Picard, A. Fischer, et al. Perforin-dependent apoptosis functionally compensates Fas deficiency in activation-induced cell death of human T lymphocytes Blood, December 15, 2007; 110(13): 4285 - 4292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Di Sabatino, R Ciccocioppo, F Cupelli, B Cinque, D Millimaggi, M M Clarkson, M Paulli, M G Cifone, and G R Corazza Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease Gut, April 1, 2006; 55(4): 469 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Arjona and D. K. Sarkar Circadian Oscillations of Clock Genes, Cytolytic Factors, and Cytokines in Rat NK Cells J. Immunol., June 15, 2005; 174(12): 7618 - 7624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Arjona, N. Boyadjieva, and D. K. Sarkar Circadian Rhythms of Granzyme B, Perforin, IFN-{gamma}, and NK Cell Cytolytic Activity in the Spleen: Effects of Chronic Ethanol J. Immunol., March 1, 2004; 172(5): 2811 - 2817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Wulfing, B. Purtic, J. Klem, and J. D. Schatzle Stepwise cytoskeletal polarization as a series of checkpoints in innate but not adaptive cytolytic killing PNAS, June 24, 2003; 100(13): 7767 - 7772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Taylor, P. M. Chaudhary, J. Klem, V. Kumar, J. D. Schatzle, and M. Bennett Inhibition of the Death Receptor Pathway by cFLIP Confers Partial Engraftment of MHC Class I-Deficient Stem Cells and Reduces Tumor Clearance in Perforin-Deficient Mice J. Immunol., October 15, 2001; 167(8): 4230 - 4237. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
